Woman in her 40s in Western Australia reported to be in hospital in a stable condition after developing clot
Health authorities have concluded a second case of a rare blood clot syndrome in Australia “is likely” linked to the AstraZeneca vaccine.
The case occurred in a woman in her 40s who received the AstraZeneca Covid-19 jab in Western Australia, the Therapeutic Goods Administration announced on Tuesday. She is receiving treatment in hospital and is in a stable condition.
Read the original article at The Guardian